Skip to main content

News & Events

  • Precision Biosciences, of Durham, and Nova Synthetix, of Chapel Hill, have initiated a “multi-year” joint research effort to generate non-genetically modified, ricin-free castor plants.
  • North Carolina fans of the life sciences will be joined in the Piedmont Triad by some national leaders on May 21 at the Sheraton Four Seasons in Greensboro for the 2014 celebration of the biannual Triad BioNight.
  • Using its own set of criteria, the trade publication Genetic Engineering & Biotechnology News (GEN) today listed the Research Triangle area the nation’s #8 biopharmaceutical cluster for 2014.
  • Weekly Grant Funding Opportunities
  • We're tired of winter too!
  • RTP offices opening at 1 p.m. today. Wintry weather has again closed and delayed some NCBiotech offices in the state. Office hours are:
  • Weekly Grant Funding Opportunities
  • By Susan Poulos ​NCBiotech Writer
  • Three young bioscience companies started with funding and other help from the North Carolina Biotechnology Center wowed the crowd at today’s opening of the 2014 CED Life Science Conference in Raleigh.
  • The North Carolina Biotechnology Center awarded more than $1.6 million in the second quarter of the 2013-2014 fiscal year, while companies in its loan portfolio brought in more than $10 million in outside funding during the period.
  • Weekly Grant Funding Opportunities
  • Michael Kelly, COO and CFO at Greensboro-based Piedmont Pharmaceuticals, has been named vice chair of the North Carolina Biotechnology Center’s Advisory Committee for Biotechnology in the Piedmont Triad.
  • Ralph Snyderman, M.D., chancellor emeritus at Duke University and James B. Duke Professor of Medicine, will receive the 2014 Life Science Leadership Award on Thursday, Feb. 27, for his contributions to the field in North Carolina.
  • Norris Tolson, President and CEO of the North Carolina Biotechnology Center, today announced that he will be stepping down, effective June 30. The NCBiotech Board of Directors will begin a search for Tolson’s successor.
  • SoyMeds, a Davidson biotech research spin-out from the University of North Carolina Charlotte, is featured in a North Carolina Science Now segment airing tonight on UNC-TV, taking viewers inside the company’s work manipulating the genetics of soybeans to create vaccines and other products to treat, prevent, cure, and diagnose disease.
  • Charlotte biopharmaceutical company Chelsea Therapeutics hit paydirt today on a market approval recommendation by the U.S. Food and Drug Administration for NORTHERA, Chelsea’s first product.
  • Weekly Grant Funding Opportunities
  • Three young bioscience companies started with funding and other help from the North Carolina Biotechnology Center will be presenters at the Innovation Showcase Feb. 26 during the 2014 CED Life Science Conference in Raleigh.
  • The North Carolina Biotechnology Center will be closed Wednesday, Feb. 12, and Thursday, Feb. 13, due to inclement weather. Our hours on Valentine's Day, Friday, Feb. 14, will depend on conditions at that time.
  • Argos Therapeutics has joined the growing ranks of companies bootstrapped by North Carolina Biotechnology Center funding that have gone on to become publicly traded, hitting the NASDAQ market at $8 a share to raise $45 million.


Subscribe to News & Events